DataKnowledgeCloudtrainingcoordination

COL A2ARV4-1 GLY 000889 (Collection)

Taxon:

Mus musculus

Taxonomy (Entity type)

Protein:

LRP2 MOUSE

Protein (Entity type)

Project:

Portal

Project (Entity type)

Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Collection:

mouse proteoform glycosylation sites embl.csv

File (Entity type)

Anatomy:

Brain

Anatomy (Entity type)

Description:Information for protein A2ARV4-1 in the context of file GLY_000889

Creation Time:2026-03-02 20:00:39.000000

Results found

Linked to

	Label	Description
	G10486CT Compound (Entity type)	type="BaseComposition" mass="1640.59217262" permass="2047.04602465" monosaccharides="9" is_motif="Fa...
	G02886BB Compound (Entity type)	type="BaseComposition" mass="1802.64499612" permass="2251.14579836" monosaccharides="10" is_motif="F...
	LRP2 MOUSE Protein (Entity type)	Low-density lipoprotein receptor-related protein 2 (precursor)
	a2arv4-1 4329asn 4329asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	a2arv4-1 1497asn 1497asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	a2arv4-1 2396asn 2396asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	a2arv4-1 3980asn 3980asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	a2arv4-1 2225asn 2225asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	a2arv4-1 3317asn 3317asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	a2arv4-1 657asn 657asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification

Compound

G10486CT

Compound (Entity type)

type="BaseComposition" mass="1640.59217262" permass="2047.04602465" monosaccharides="9" is_motif="Fa...

Compound

G02886BB

Compound (Entity type)

type="BaseComposition" mass="1802.64499612" permass="2251.14579836" monosaccharides="10" is_motif="F...

Protein

LRP2 MOUSE

Protein (Entity type)

Low-density lipoprotein receptor-related protein 2 (precursor)

Post Translational Modification

a2arv4-1 4329asn 4329asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

a2arv4-1 1497asn 1497asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

a2arv4-1 2396asn 2396asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

a2arv4-1 3980asn 3980asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

a2arv4-1 2225asn 2225asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

a2arv4-1 3317asn 3317asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

a2arv4-1 657asn 657asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.